加科思-B 港股通 空最新回购 (2026-07-23) 官网 ( 01167.hk) | -24.52 | 4.64 | 0% | 上市时间2020-12-21股价5.03港币涨跌幅-0.40%成交金额1,217.32万港币换手率0.30%市值39.83亿港币H股市值39.83亿港币总股本7.92亿H股本7.92亿每手股数300上市至今年化投资收益率-17.25%港股通持仓占H股比例4.23% (1.70亿港币2026-07-21) 累计做空占H股比例2.36% (8,677.90万港币2026-07-17) | |||
| 所属三级行业生物技术 (恒生) | 市盈率 | 122.29 | 市净率 | 4.46 | 股息率 | 0.37% | 恒生:医疗保健业药品及生物科技生物技术 |
| 备注 (3): | 双击编辑备注 |
加科思-B(01167) - 历史董事名单
| # | 姓名 | 职衔 | 职位 | 委任日期 | 辞任日期 |
|---|---|---|---|---|---|
| 1 | 魯白 | Independent Non Executive Director | 2023-03-23 | -- | |
| 2 | 宋瑞霖 | Independent Non Executive Director | 2020-12-21 | -- | |
| 3 | 吳革 | Independent Non Executive Director - A/F | 2020-12-21 | -- | |
| 4 | 蔡大慶 | Independent Non Executive Director | 2020-12-21 | 2023-03-23 | |
| 5 | 吳曉明 | Independent Non Executive Director | 2020-12-21 | 2022-03-22 | |
| 6 | 呂東 | Non Executive Director | 2020-11-30 | 2023-08-30 | |
| 7 | 陳德禮 | Non Executive Director | 2020-08-20 | -- | |
| 8 | 馮婷 | Non Executive Director | 2020-02-27 | 2022-03-22 | |
| 9 | 唐豔旻 | Non Executive Director | 2018-08-22 | -- | |
| 10 | 胡雲雁 | Executive Director | 2018-07-31 | -- | |
| 11 | 王曉潔 | Executive Director | 2018-07-31 | -- | |
| 12 | 胡邵京 | Executive Director | 2018-07-31 | 2022-03-22 | |
| 13 | 王印祥 | Executive Director | Chairman, CEO | 2018-06-01 | -- |